19
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Ulcerative Colitis and Colorectal Carcinoma: DNA-Profile, Laminin-5 ?2 Chain and Cyclin A Expression as Early Markers for Risk Assessment

Pages 751-758 | Published online: 08 Jul 2009

References

  • Ekbom A, Helmick C, Zack M, Adami HO. Ulcerative colitis and colorectal cancer. A population based study. N Engl J Med 1990;323:1228–33.
  • Collins RH, Feldman M, Fordtran JS. Colon cancer, dysplasia, and surveillance in patients with ulcerative colitis; a critical review. N Engl J Med 1987;316:1655–8.
  • Ridell RH, Goldman H, Ransohoff DF, Appelman HD, Fenoglio CM, Haggitt RC, et al. Dysplasia in inflammatory bowel disease. Hum Pathol 1983;14:931–68.
  • Rubin CE, Haggitt RC, Burmer GC, Brentnall TA, Stevens AC, Levine DS, et al. DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology 1992;103:1611–20.
  • Weitberg AB. Effect of combinations of antioxidants on phagocyte-induced stister-chromatid exchanges. Mutat Res 1989;224:1–4.
  • Holzman K, Klump B, Borchard F, Hsieh CJ, Kuhn A, Gaco V, et al. Comparative analysis of histology, DNA content, p53 and Ki-ras mutations in colectomy specimens with long-standing ulcerative colitis. Int J Cancer 1998;76:1–6.
  • Löfberg R, Broström O, Karlen P, Tribukeit B, Öst Å. DNA aneuploidy in ulcerative colitis: reproducibility, topographic distribution and relation to dysplasia. Gastroenterology 1992;102:1149–54.
  • Iivanainen A, Morita T, Tryggvason K. Molecular cloning and tissue-specific expression of a novel murine laminin gamma 3 chain. J Biol Chem 1999;274: 14107–11.
  • Tryggvason K. The laminin family. Curr Opin Cell Biol 1993;5:877–82.
  • Carter WG, Ryan MC, Gahr PJ. Epilegrin, a new cell adhesion ligand for integrin alpha 3 beta 1 in epithelial basement membranes. Cell 1991;65: 599–610.
  • Pyke C, Romer J, Kallunki P, Lund LR, Ralfkiaer E, Dano K, et al. The gamma 2 chain of kalinin/laminin-5 is preferentially expressed in invading malignant cells in human cancers. Am J Pathol 1994;145:782–91.
  • Pyke C, Salo S, Ralfkiaer E, Romer J, Dano K, Tryggvason K. Laminin-5 is a marker of invading cancer cells in some human carcinomas and is coexpressed with the receptor for urokinase plasminogen activator in budding cancer cells in colon adenocarcinomas. Cancer Res 1995;55:4132–39.
  • Sordat I, Bosman FT, Dorta G, Rousselle P, Aberdam D, Blum AL, et al. Differential expression of laminin-5 subunits and integrin receptors in human colorectal neoplasia. J Pathol 1998;185:44–52.
  • Sherr CJ. Mammalian G1 cyclins. Cell 1993;73:1059–65.
  • Zindy F, Lamas E, Chenivesse X, Sobczak J, Wang J, Fesquet D, et al. Cyclin A is required in S phase in normal epithelial cells. Biochem Biophys Res Commun 1992;182:1144–54.
  • Handa K, Yamakawa M, Takeda H, Kimura S, Takahshi T. Expression of cell cycle markers in colorectal carcinoma: superiority of cyclin A as an indicator of poor prognosis. Int J Cancer 1999;84:225–33.
  • Salo S, Haakana H, Kontusaari S, Hujanen E, Kalluna T, Tryggvason K. Laminin-5 promotes adhesion and migration of epithelial cells. Matrix Biol 1999;18:197–210.
  • Auer G, Caspersson T, Wallgren A. DNA content and survival in mammary carcinoma. Analyt Quant Cytol Histol 1980;2:161–5.
  • Dobbins WO III. Current status of the precancer lesion in ulcerative colitis. Gastroenterology 1977;73:1431–3.
  • Lynch DA, Lobo AJ, Sobala GM, Dixon MF, Axon AT. Failure of colonoscopic surveillance in ulcerative colitis. Gut 1993;34:1075–80.
  • Schimmelpenning H, Hamper K, Askensten UG, Caselitz J, Seifert G, Auer GU. Methodological aspects of DNA assessments by means of image cytometry in tumors of the salivary glands. Anal Quant Cytol Histol 1989;11:379–83.
  • Willenbucher RF, Aust DE, Chang CG, Zelman SJ, Ferell LD, Moore II DH, et al. Genomic instability is an early event during the progression pathway of ulcerative-colitis-related neoplasia. Am J Pathol 1999;154:1825–30.
  • Skyldberg B, Salo S, Eriksson E, Aspenblad U, Moberger B, Tryggvason K, et al. Laminin-5 as a marker of invasiveness in cervical lesions. J Natl Cancer Inst 1999;91:1882–7.
  • Larjava H, Salo T, Haapasalmi K, Kramer RH, Heino J. Expression of integrins and basement membrane components by wound keratinocytes. J Clin Invest 1993;92:1425–35.
  • Haapasalmi K, Makela M, Oksala O, Heino J, Yamada KM, Uitto VJ. Expression of epithelial adhesion proteins and integrins in chronic inflammation. Am J Pathol 1995;147:193–206.
  • Thorup AK, Reibel J, Schiødt M, Srenersen TC, Therkidsen MH, Carter WG, et al. Can alterations in integrin and laminin-5 expression be used as markers of malignancy? APMIS 1998;106: 1170–80.
  • Ono J, Auer G, Caspersson T, Nasiell M, Saito T, Konaka C, et al. Reversibility of 20-methylcholanthrene-induced bronchial cell atypia in dogs. Cancer 1984;54:1030–7.
  • Auer G, Ono J, Nasiell M, Caspersson T, Kato H, Konaka C, et al. Reversibility of bronchial cell atypia. Cancer Res 1982;42:4241–7.
  • Wang A, Yoshimi N, Suzui M, Yamauchi A, Tarao M, Mori H. Different expression patterns of cyclin A, D1 and E in human colorectal cancer. J Cancer Res Clin Oncol 1996;122:122–6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.